Table 1.
Characterization of COVID-19 blood samples
Whole blood | |||
---|---|---|---|
Patient # | Antigen test | Our test | Note |
1* | Positive | Positive | Onset |
1* | Negative | Negative | Recovered |
2 | Negative | Negative | |
3 | Negative | Negative | |
4 | Negative | Negative | |
5 | Positive | Positive | |
6 | Positive | Positive | |
7 | Negative | Negative | |
8 | Negative | Negative | |
9 | Positive | Positive | |
10 | Negative | Negative | |
11** | Positive | Negative | PCR negative (so, deemed negative) |
12 | Negative | Negative | |
13 | Positive | Positive | |
14** | positive | negative | PCR result unavailable |
15 | Positive | Positive | |
16 | Positive | Positive | |
17 | Positive | Positive | |
18 | positive | negative | PCR result unavailable |
19 | Negative | Negative | |
20 | Negative | Negative | |
21 | Negative | Negative | |
22 | Negative | Negative | |
23 | Negative | Negative | |
24 | Negative | Negative | |
25 | positive | negative | PCR result unavailable |
26 | Negative | Negative | |
27 | positive | negative | PCR result unavailable |
28 | Negative | Negative | |
*from same patient with mild symptoms. **discrepancy between antigen and our tests. Prevalence of COVID-19-positive cases collected in the point-of-care clinic: 14/29 = 48.3%. |
plasma, #2-#14 are sera.
discrepancy. Prevalence of COVID-19-positive cases collected in the hospital: 7/14 = 50%.